When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CytoDyn's (CYDY) high-energy CEO Nadir Pourhassan [NP] has been in his element in the fast-paced news cycle attendant upon all things COVID-19. Today, as I write on 4/7/20, he has responded to both a Charles Payne Fox Business interview along with another in his series of regular Proactive YouTube interviews, both interviews promoting leronlimab's recent COVID-19 achievements.
Leronlimab has staked a claim as a possible therapy for treatment of COVID-19
When I first noticed that CytoDyn was laying a claim to leronlimab as a COVID-19 (then known by the name Novel Coronavirus 2019-nCov)